SciSparc Ltd.

SciSparc Ltd.verified

SPRC

Price:

$0.2212

Market Cap:

$2.29M

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and...[Read more]

Industry

Biotechnology

IPO Date

2021-08-30

Stock Exchange

NASDAQ

Ticker

SPRC

The Enterprise Value as of December 2024 (TTM) for SciSparc Ltd. (SPRC) is 290.99K

According to SciSparc Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 290.99K. This represents a change of -59.46% compared to the average of 717.87K of the last 4 quarters.

SciSparc Ltd. (SPRC) Historical Enterprise Value (quarterly & annually)

How has SPRC Enterprise Value performed in the past?

The mean historical Enterprise Value of SciSparc Ltd. over the last ten years is 2.46B. The current 290.99K Enterprise Value has changed -98.82% with respect to the historical average. Over the past ten years (40 quarters), SPRC's Enterprise Value was at its highest in in the June 2016 quarter at 4.17B. The Enterprise Value was at its lowest in in the June 2022 quarter at -6085214.10.

Quarterly (TTM)
Annual

Average

2.46B

Median

852.21M

Minimum

-267824.48

Maximum

13.65B

SciSparc Ltd. (SPRC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SciSparc Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 211.50%

Maximum Annual Enterprise Value = 13.65B

Minimum Annual Increase = -101.37%

Minimum Annual Enterprise Value = -267824.48

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-267824.48205.71%
2022-87606.74-101.37%
20216.39M-96.14%
2020165.50M-78.56%
2019771.80M-17.24%
2018932.62M-93.17%
201713.65B211.50%
20164.38B57.10%
20152.79B48.34%
20141.88B58.09%

SciSparc Ltd. (SPRC) Average Enterprise Value

How has SPRC Enterprise Value performed in the past?

The current Enterprise Value of SciSparc Ltd. (SPRC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.01M

5-year avg

188.67M

10-year avg

2.46B

SciSparc Ltd. (SPRC) Enterprise Value vs. Peers

How is SPRC’s Enterprise Value compared to its peers?

SciSparc Ltd.’s Enterprise Value is greater than OncoSec Medical Incorporated (-4472153.00), less than Virax Biolabs Group Limited (4.10M), less than Hillstream BioPharma, Inc. (1.48M), less than ZyVersa Therapeutics, Inc. (2.57M), less than Unicycive Therapeutics, Inc. (38.02M), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), less than Cardio Diagnostics Holdings, Inc. (39.58M), less than PaxMedica, Inc. Common Stock (371.78K), less than YS Biopharma Co., Ltd. (781.13M), less than Cadrenal Therapeutics, Inc. Common Stock (20.14M), greater than Virios Therapeutics, Inc. (-2813681.00), greater than Hoth Therapeutics, Inc. (-2555665.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (53.76M), less than Assembly Biosciences, Inc. (66.55M), less than Instil Bio, Inc. (221.53M), less than Nuvation Bio Inc. (930.27M), less than Blue Water Vaccines, Inc. (12.48M), greater than Revelation Biosciences, Inc. (-4029924.00), less than Kiora Pharmaceuticals, Inc. (4.31M),

Build a custom stock screener for SciSparc Ltd. (SPRC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SciSparc Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SciSparc Ltd. (SPRC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SciSparc Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is SciSparc Ltd.'s Enterprise Value?

What is the highest Enterprise Value for SciSparc Ltd. (SPRC)?

What is the 3-year average Enterprise Value for SciSparc Ltd. (SPRC)?

What is the 5-year average Enterprise Value for SciSparc Ltd. (SPRC)?

How does the current Enterprise Value for SciSparc Ltd. (SPRC) compare to its historical average?